How it works.
PT-141 is a synthetic analog of α-MSH, engineered as a cyclic heptapeptide with selective agonist activity at MC3R and MC4R melanocortin receptors. Unlike PDE5 inhibitors, which act on vascular smooth muscle, PT-141's mechanism is centrally mediated — its receptor activity is in the hypothalamus, not the periphery. Research has documented effects on sexual response pathways in animal and clinical models, with a pharmacokinetic profile suited to subcutaneous administration in research protocols.
Verified buyer notes.
Initials only — every quote is verified against an order record. We don’t ghost-write reviews.
“COA matched what we ran in-house. Powder reconstituted clean, no haze. Did exactly what we needed it to.”
“Switched after two bad lots from a previous source. Three orders in, zero issues.”
“Shipment got delayed two days by weather and still arrived at 4°C. Packaging is no joke.”
The shared signature.
04Coming soonA dual GIP/GLP-1 receptor agonist studied for its effects on glycemic regulation and adipose tissue metabolism.
04Coming soonA long-acting GLP-1 receptor agonist studied for its effects on glycemic control, satiety signaling, and adipose tissue.
04Coming soonA long-acting amylin analog studied as an adjunct to GLP-1 agonism in metabolic research.